Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Dual defense: Opportunities and challenges of GLP-1 receptor agonists in reducing dementia risk in type 2 diabetes!

Created on 30 May 2025

Authors

Saman Adnan, Muniza Qureshi, Sania Arif, Kinza Fatima

Published in

Alzheimer's & dementia : the journal of the Alzheimer's Association. Volume 21. Issue 5. Pages e70336.

PMID:
40442874
Bibliographic data and abstract were imported from PubMed on 30 May 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 25
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement